OraSure Technologies Says FDA Clears At-Home Urine Collection Kit for STI Testing

MT Newswires Live
06/11

OraSure Technologies (OSUR) has received US Food and Drug Administration clearance for its Colli-Pee Dx Urine Collection Kit for use with Roche molecular tests for chlamydia, gonorrhea, trichomoniasis and mycoplasma genitalium, the company said Thursday.

The clearance allows patients to self-collect urine samples at home or in other private settings for testing on Roche's molecular diagnostic systems, OraSure said.

The company said the kit uses its NucleoPrecision technology to stabilize DNA and RNA and maintain sample integrity at ambient temperatures.

Shares of the company were over 3% higher in Thursday premarket trading.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10